|Room 4331, 3th building, high-tech industrial park, yizhi road, qingshan district, wuhan, China||Body@bodybiological.com|
|Place of Origin:||Hubei, China|
|Minimum Order Quantity:||10gram|
|Packaging Details:||Foil bag|
|Delivery Time:||3-7 days|
|Payment Terms:||T/T, Western Union, MoneyGram|
|CAS:||107724-20-9||Shipping Method:||Fedex, TNT, DHL, UPS, HK EMS|
|Payment Terms:||Money Gram, Western Union, Bank Transfer||MOQ:||10gram|
|Purity:||99.8%||Export Market:||USA UK, Brazil, Thailand, Canada|
legal anabolic steroids,
oral bodybuilding steroids
25mg/Tablet Oral Pharmcy Material Eplerenone Steroid CAS107724-20-9
Product Name: Eplerenone
Chemical Name: Pregn-4-ene-7, 21-dicarboxylic acid 9, 11-epoxy-17-hydroxy-3-oxo gamma-
Lactone methyl ester
Product Categories: Steriods
CAS No.: 107724-20-9
Standard: Enterprise Standard
Appearance: White crystalline powder; Slightly soluble in water.
Molecular Formula: C24H30O6
Molecular weight: 414.49
Usage: Selective aldosterone receptor antagonist (SARA), structurally similar to Spiranolactone. Eplerenone is used alone or in combination with other medications to treat high blood pressure. Eplerenone is in a class of medications called mineralocorticoid receptor antagonists. It works by blocking the action of aldosterone, a natural substance in the body that raises blood pressure.
Eplerenone (INN) is a steroidal antimineralocorticoid of the spirolactone group that is used as an adjunct in the management of chronic heart failure. It is similar to the diuretic spironolactone, though it is much more selective for the mineralocorticoid receptor in comparison (i.e., does not possess any antiandrogen, progestogen, glucocorticoid, or estrogenic effects), and is specifically marketed for reducing cardiovascular risk in patients following myocardial infarction. Eplerenone is a potassium-sparing diuretic, meaning that it helps the body get rid of water but still keep potassium.
Eplerenone was developed by Pharmacia Corporation, which was acquired by Pfizer in 2002. It was marketed by Pfizer under the trade name Inspra. The US Food and Drug Administration (FDA) approved the drug for sale in the United States in 2002. Eplerenone is currently approved for sale in the US, EU, Netherlands and Japan. Relative to dosage, eplerenone costs an estimated $2.93 per day when treating congestive heart failure and $5.86 per day when treating hypertension
Eplerenone is an odorless, white to off-white crystalline powder. It is very slightly soluble in water, with its solubility essentially pH-independent. The octanol/water partition coefficient of eplerenone is approximately 7.1 at pH 7.0.
INSPRA tablets for oral administration contain 25 mg or 50 mg of eplerenone and the following inactive ingredients: lactose, microcrystalline cellulose, croscarmellose sodium, hypromellose, sodium lauryl sulfate, talc, magnesium stearate, titanium dioxide, polyethylene glycol, polysorbate 80, and iron oxide yellow and iron oxide red.
INSPRA is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular (CV) events, primarily strokes and MI. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes.
Other related products:
|13||CJC-1295 without DAC||2mg||98%|
|14||CJC-1295 with DAC||2mg||98%|
|20||BPC 157 (Pentadecapeptide)||5mg||98%|
Contact Person: Penny